FDA issues modified risk orders for 20 ZYN nicotine pouch products

The FDA has authorized Philip Morris International's ZYN nicotine pouches for reduced-risk marketing. This marks the first such approval for a nicotine pouch product in the United States. The regulator concluded ZYN could significantly reduce harm compared to cigarette smoking. This decision allows adult nicotine users access to science-based health information. The authorization applies to specific marketing claims and authorized ZYN products.